id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-2873-0007,FDA,FDA-2022-D-2873,Voluntary Malfunction Summary Reporting Program for Manufacturers; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2024-08-29T04:00:00Z,2024,8,,,2024-08-29T13:05:57Z,2024-19413,0,0,09000064866b3505
FDA-2022-D-2873-0008,FDA,FDA-2022-D-2873,Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers; Guidance for Industry and Food and Drug Administration Staff; Final Guidance,Other,Guidance,2024-08-29T04:00:00Z,2024,8,2024-08-29T04:00:00Z,,2024-11-12T22:43:20Z,,1,0,09000064866b3719
FDA-2022-D-2873-0001,FDA,FDA-2022-D-2873,Voluntary Malfunction Summary Reporting Program for Manufacturers; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2022-12-09T05:00:00Z,2022,12,2022-12-09T05:00:00Z,2023-02-08T04:59:59Z,2023-02-08T02:00:44Z,2022-26729,0,0,090000648552a72e
FDA-2022-D-2873-0002,FDA,FDA-2022-D-2873,Draft Guidance for Industry and FDA Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers,Other,Guidance,2022-12-09T05:00:00Z,2022,12,2022-12-09T05:00:00Z,,2024-08-29T13:12:48Z,,0,0,090000648552b73e